| Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. | |
| | |
MedLine Citation:
|
PMID: 15755876 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Histone deacetylase (HDAC) inhibitors are emerging as a promising new class of cancer therapeutic agents. HDAC inhibitors relieve the deacetylation of histone proteins. However, little is known about the nonhistone targets of HDAC inhibitors and their roles in gene regulation. In this study, we addressed the molecular basis of the down-regulation of the nuclear factor-kappaB (NF-kappaB)-responsive gene cyclin D1 by the HDAC inhibitor trichostatin A in mouse JB6 cells. Cyclin D1 plays a critical role in cell proliferation and tumor progression. Trichostatin A inhibits cyclin D1 expression in a NF-kappaB-dependent manner in JB6 cells. Electrophoretic mobility shift assay studies showed that trichostatin A treatment prevents p65 dimer binding to NF-kappaB sites on DNA. Moreover, a chromatin immunoprecipitation assay shows that trichostatin A treatment inhibits endogenous cyclin D1 gene transcription by preventing p65 binding to the cyclin D1 promoter. However, acetylation of p65 is not affected by trichostatin A treatment. Instead, trichostatin A enhances p52 acetylation and increases p52 protein level by enhancing p100 processing. This is the first report that trichostatin A, a HDAC inhibitor, activates p100 processing and relieves the repression of p52 acetylation. The enhanced acetylation of p52 in the nuclei may operate to cause nuclear retention of p65 by increasing the p52/p65 interaction and preventing IkappaBalpha-p65 binding. The enhanced p52 acetylation coincides with decreased p65 DNA binding, suggesting a potential role of p52 acetylation in NF-kappaB regulation. Together, the results provide the first demonstration that HDAC inhibitor trichostatin A inhibits cyclin D1 gene transcription through targeting transcription factor NF-kappaB/p65 DNA binding. NF-kappaB is therefore identified as a transcription factor target of trichostatin A treatment. |
| | |
Authors:
|
Jing Hu; Nancy H Colburn |
Related Documents
:
|
15576936 - E2f transcription factors and prb pocket proteins in cell cycle progression. 12420226 - The rb-family protein p107 inhibits translation by a pdk1-dependent mechanism. 19084516 - Scf(fbxw7/hcdc4) targets cyclin e2 for ubiquitin-dependent proteolysis. 14684736 - Cyclin l2, a novel rna polymerase ii-associated cyclin, is involved in pre-mrna splicin... 12408996 - Cloning and localization of rgpr85 encoding rat g-protein-coupled receptor. 15878846 - The rna-binding protein hur binds to acetylcholinesterase transcripts and regulates the... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Molecular cancer research : MCR Volume: 3 ISSN: 1541-7786 ISO Abbreviation: Mol. Cancer Res. Publication Date: 2005 Feb |
Date Detail:
|
Created Date: 2005-03-09 Completed Date: 2005-08-04 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 101150042 Medline TA: Mol Cancer Res Country: United States |
Other Details:
|
Languages: eng Pagination: 100-9 Citation Subset: IM |
Affiliation:
|
Gene Regulation Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute-Frederick, Building 567, Room 188, Frederick, MD 21702, USA. huji@ncifcrf.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetylation
/
drug effects Animals Cells, Cultured Cyclin D1 / genetics, metabolism* DNA-Binding Proteins / metabolism Down-Regulation* Histone Deacetylase Inhibitors* Hydroxamic Acids / pharmacology* Mice NF-kappa B / metabolism* NF-kappa B p52 Subunit Phosphorylation / drug effects Promoter Regions, Genetic / genetics, physiology Transcription Factor RelA Transcription, Genetic / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/DNA-Binding Proteins; 0/Histone Deacetylase Inhibitors; 0/Hydroxamic Acids; 0/NF-kappa B; 0/NF-kappa B p52 Subunit; 0/Transcription Factor RelA; 136601-57-5/Cyclin D1; 58880-19-6/trichostatin A |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-i...
Next Document: A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA...